News + Font Resize -

Zydus gets US FDA approval to market metoprolol succinate ER tablets USP

Our Bureau, Mumbai | Monday, March 26, 2018, 13:30 Hrs [IST]

Zydus Cadila has received the final approval from the US FDA to market metoprolol succinate Extended-Release tablets USP in the strengths of 25 mg, 50 mg, 100 mg and 200 mg. The drug is used to treat chest pain (angina), heart failure and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

The group now has more than 185 approvals and has so far filed over 320 ANDAs since the commencement of the filing process in FY 2003-04.

Comments

Ray Ellis

Apr 6, 2018 1:28 AM

Most heart disease is caused by multiple nutritional deficiencies and - like all other nutritional deficiency diseases - it can be reversed by supplying the missing nutrient(s). Dr. Thomas E. Levy has been a cardiologist for over 30 years. In his book, Stop America’s #1 Killer, he lists 33 nutrients “…for optimizing the ability of the artery to regenerate itself and reverse any existing atherosclerosis…the typical diet does not even come close to supplying enough of these essential vitamins, minerals and nutrients.” As someone with a family history of heart disease, I have been taking this list of nutrients since 2000. I am now 63 years old and recently had an MRI. The doctor declared, “Ray, your arteries are clean as a whistle!” Needless to say, I am a big fan of Dr. Levy and am dedicated to disseminating this important information; so, I email this list - along with the proper dosages - to anyone who requests it. Just email me at: rayellis@reagan.com.

Spencer Seto	Mar 26, 2018 5:23 PM
Its a good news by giving approval for these illness of the body problems, mainly heart attacks and kidney problems.